Stefano Luminari
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment 175
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 57
- Oncology top 1%
- Viral-associated cancers and disorders 56
- CAR-T cell therapy research 13
- Neurology top 0.5%
- CNS Lymphoma Diagnosis and Treatment 43
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 18
-
- Lung Cancer Treatments and Mutations 40
-
- Medical Imaging Techniques and Applications 11
- Co-authors
- Massimo FedericoFrancesco MerliLuigi MarcheselliCaterina StelitanoLuigi RigacciUmberto VitoloMonica BelleiFrancesco Di Raimondo
- Journals
- Blood (39 papers)Journal of Clinical Oncology (33 papers)Hematological Oncology (23 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Stefano Luminari
195 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Pathology and Forensic Medicine 4.3k
- Genetics 1.2k
- Oncology 2.6k
- Neurology 1.3k
- Reproductive Medicine 366
Countries citing papers authored by Stefano Luminari
This map shows the geographic impact of Stefano Luminari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Luminari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Luminari more than expected).
Fields of papers citing papers by Stefano Luminari
This network shows the impact of papers produced by Stefano Luminari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Luminari. The network helps show where Stefano Luminari may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stefano Luminari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2021 | 4 | |
| 7 | 2020 | 16 | |
| 8 | 2019 | 11 | |
| 9 | 2018 | 52 | |
| 10 | 2018 | 0 | |
| 11 | 2018 | 31 | |
| 12 | 2018 | 3 | |
| 13 | High-risk follicular lymphoma patients: Identification and treatment | 2018 | 1 |
| 14 | 2015 | 28 | |
| 15 | 2015 | 13 | |
| 16 | 2012 | 88 | |
| 17 | R-CVP versus R-CHOP versus R-FM as first-line therapy for advanced-stage follicular lymphoma: Final results of FOLL05 trial from the Fondazione Italiana Linfomi (FIL) | 2012 | 6 |
| 18 | patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial | 2011 | 1 |
| 19 | Early Interim 2-[ 18 F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Studybreakdown → | 2007 | 552 |
| 20 | CD5 negative chronic B cell leukemias : a polycentric retrospective study | 2005 | 1 |
About Stefano Luminari
Stefano Luminari is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 216 papers that have together received 5.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (175 papers), Chronic Lymphocytic Leukemia Research (57 papers), Viral-associated cancers and disorders (56 papers), CNS Lymphoma Diagnosis and Treatment (43 papers), Lung Cancer Treatments and Mutations (40 papers), Ovarian cancer diagnosis and treatment (18 papers), CAR-T cell therapy research (13 papers) and Medical Imaging Techniques and Applications (11 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.3k citations), Genetics (1.2k citations) and Oncology (2.6k citations). Stefano Luminari has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Massimo Federico, Francesco Merli, Luigi Marcheselli, Caterina Stelitano, Luigi Rigacci, Umberto Vitolo, Monica Bellei, Francesco Di Raimondo, Annibale Versari and Luca Baldini. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, Annals of Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.